Centre de recherche sur le vieillissement
Sherbrooke, Quebec, J1H 4C4, Canada
NCT Number: NCT01883674
This project evaluates the use of different types of proteins from various food sources after an exercise session, on muscle mass and physical capacity in aged sarcopenic men (who have low muscle mass). Specifically, researchers want to:
* Examine the efficiency of protein intake after exercise on muscle mass and physical abilities; * Examine the impact of exercise and proteins on blood lipids (LDL cholesterol, HDL cholesterol, total cholesterol and triglycerides); * Examine the impact of exercise and proteins on liver enzymes; * Examine the impact of exercise and proteins on a hormone that controls hunger; * Evaluate the program's impact on the ability of the body to produce energy.
All participants are exercising (resistance training) and ingest one of the 3 different sources of proteins, immediately after training:
* Milk proteins (from milk beverage) * Essential amino acids (added to a soya beverage) * No protein (rice beverage - control group)
Our hypothesis is that proteins from milk will induce a gain in muscle mass and physical function equivalent to the essential amino acids (EAA). We anticipate that both milk proteins and EAA will be both superior to control group.
This would represent an interesting finding since milk is more accessible, palatable and cheaper than essential amino acids commercial mix.
Looking for future studies?
Notify Me65 year–75 year
Male
Interventional
Not applicable
Sherbrooke, Quebec, J1H 4C4, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All group will exercise 3x/week. Each session of resistance training will last 60min. and will target main muscular groups.
Time frame: At baseline and post intervention (17th week)
Time frame: At baseline and post intervention (17th week)
Time frame: At baseline and post intervention (17th week)
Plasmatic IL-6 anf TNF-alpha
Time frame: At baseline and post intervention (17th week)
Apolipoproteins (Apo-AI, Apo-AII, Apo-B); Total cholesterol, HDL, LDL and triglycerides.
Time frame: At baseline, mid (8th week) and post intervention (17th week)
Blood marker on renal function will be assessed to ensure the safety of the supplementation of protein intake on renal function in sarcopenic men.
Time frame: At baseline and post intervention (17th week)
Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT) and Alkaline phosphatase (ALP).
Time frame: At baseline and post intervention (17th week)
Time frame: At baseline, mid (8th week) and post intervention (17th week)
3-day food record - Control variable (in order to verify if changes we observe through the intervention are accountable or not for dietary intakes)
Time frame: At baseline and post intervention (17th week)
Physical Activity Scale for the Elderly (PASE) - Control variable (in order to verify if changes we observe through the intervention are accountable or not for daily physical activity level)
Université de Sherbrooke
Other
Acronym: PRO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07629063
Atrophy, Basal Ganglia Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04255745
Atrophy, Behavior
Chicago, Illinois, United States
View Trial DetailsNCT06288828
Aerobic Exercises, Atrophy
Bangkok, Thailand
View Trial DetailsNCT05294757
Atrophy, Behavior
Albacete, Castille-La Mancha, Spain
View Trial Details